Aureus Asset Management, LLC Glaukos Corp Transaction History

Aureus Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $399,272 - $533,930	-5,465 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $10,647 - $14,577	-286 Reduced 4.97%	5,465 $271,000
Q2 2020 Aug 11, 2020	BUY	$28.78 - $46.83 $165,513 - $269,319	5,751 New	5,751 $221,000
Q1 2020 May 14, 2020	SELL	$25.53 - $70.14 $289,791 - $796,159	-11,351 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$54.18 - $65.64 $614,997 - $745,079	11,351 New	11,351 $618,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.